Connection

Jean-Charles Soria to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Clinical Trials, Phase II as Topic.
Jean-Charles Soria
Connection Strength
0.034
Clinical Trials, Phase II as Topic
  1. Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy. J Clin Oncol. 2018 03 20; 36(9):850-858.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.